Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population

Europace

Volumn 16, Issue 2, 2014, Pages 227-234

  Buber, Jonathan ^a,b   Luria, David ^a,b   Gurevitz, Osnat ^a,b   Bar Lev, David ^a,b   Eldar, Michael ^a,b   Glikson, Michael ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Implantable cardiac defibrillators; Inappropriate shocks; Strategic programming

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; DEATH; DEVICE SAFETY; ELECTRIC SHOCK; FAINTNESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SINUS TACHYCARDIA; SUDDEN CARDIAC DEATH;

IMPLANTABLE CARDIAC DEFIBRILLATORS; INAPPROPRIATE SHOCKS; STRATEGIC PROGRAMMING;

AGED; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SYNCOPE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84893208434     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut302     Document Type: Article

References (21)

1. Moss AJ, Hall WJ,Cannom D.S., Daubert JP, Higgins SL, Klein H.et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37.
4. Epstein AE, Dimarco JP, Ellenbogen JA, EstesNA3rd, Freedman RA, Gettes LS et al.; ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 2008;117:e350-408.
5. Freedenberg V, Thomas SA, Friedman E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin 2011;7:59-68.
6. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B,Wallace R et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000;23:939-45.
7. Mofrad PS, Ottoboni L, Zei PC, Hsia HH, Wang PJ, Amin-Al-Ahmad. VF and fatal cardiac arrest following ICD therapy delivery: what is the cause? Pacing Clin Electrophysiol 2007;30:551-3.
8. Poole JE, Johnson G.W., Hellkamp AS, Anderson J, Callans DJ, Raitt M.H.et al. Prognostic importance of defibrillator shocks in patients with heart failure.NEngl J Med 2008; 359:1009-17.
9. Daubert JP, Zareba W., Cannom DS, McNitt S, Rosero SZ,Wang P et al.; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
10. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ et al. Inappropriate implantable cardioverter-defibrillator shocks. Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011;57:556-62.
11. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, LeeSWet al.; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients results from the PREPARE (Primary Prevention Parameters Evaluation) Study. J Am Coll Cardiol 2008;52:541-50.
12. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, for the EMPIRIC Trial Investigators.Acomparison of EMpiric to Physiciantailored progRamming of Implantable Cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006;48:330-9.
13. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with Left VentriculAR dysfunction, Nonischemic eTiology in primary prevention and treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67.
14. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythmdiagnosis: the detect supraventricular tachycardia study. Circulation 2006;113:2871-9.
15. Theuns DA, Rivero-Ayerza M, Boersma E, Jordaens L. Prevention of inappropriate therapy in implantable defibrillators: a meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 2008;125:352-7.
16. Powell BD, Cha YM, Asirvatham SJ, Cesario DA, Cao M, Jones P.W.et al. Implantable cardioverter defibrillator electrogram adjudication for device registries: methodology and observations from ALTITUDE. Pacing Clin Electrophysiol 2011;34: 1003-12.
17. Friedman P, Slusser J, Hodge D, Bradley D., Koestler C, Kusumoto F et al. Prospective randomized trial of dual chamber vs. single chamber ICDs to minimize shocks in optimally programmed devices. Abstract presented at: Heart RhythmSociety Scientific Sessions; May 12, 2012; Boston, MA, USA.
18. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al.; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83.
19. Gasparini M., Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB et al. Effect of longdetection interval vs. standard-detection interval for implantable cardioverterdefibrillators on antitachycardia pacing and shock delivery: theADVANCE III randomized clinical trial. JAMA 2013;309:1903-11.
20. Diemberger I, Martignani C, Biffi M, Frabetti L, Valzania C, Cooke RM et al. Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. Int J Cardiol 2012;154:134-40.
21. Gasparini M, Nisam S. Implantable cardioverter defibrillator harm? Europace 2012; 14:1087-93.